Integraza (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Integraza" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

49^th place

103^rd place

low place

1^st place

28^th place

89^th place

clinicaloptions.com

Morales-Ramirez JO, Teppler H, Kovacs C, et al. Antiretroviral effect of MK-0518, a novel HIV-1 integrase inhibitor, in ART-naïve HIV-1 infected patients. Program and abstracts of the 10th European AIDS Conference; November 17–20, 2005; Dublin, Ireland. Abstract LBPS1/6. Online summary: http://clinicaloptions.com/HIV/Conference%20Coverage/Dublin%202005/Capsules/LBPS1-6.aspx Архивирано на сајту Wayback Machine (29. октобар 2006)

Lodi PJ, Ernst JA, Kuszewski J, Hickman AB, Engelman A, Craigie R, Clore GM, Gronenborn AM (1995). „Solution structure of the DNA binding domain of HIV-1 integrase”. Biochemistry. 34 (31): 9826—33. PMID 7632683. doi:10.1021/bi00031a002.
Savarino A (2006). „A historical sketch of the discovery and development of HIV-1 integrase inhibitors”. Expert Opin Investig Drugs. 15 (12): 1507—22. PMID 17107277. doi:10.1517/13543784.15.12.1507.
Sax PE, DeJesus E, Mills A, Zolopa A, Cohen C, Wohl D, Gallant JE, Liu HC, Zhong L, Yale K, White K, Kearney BP, Szwarcberg J, Quirk E, Cheng AK (2012). „Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks”. Lancet. 379 (9835): 2439—48. PMID 22748591. doi:10.1016/S0140-6736(12)60917-9.
Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P (2010). „Retroviral intasome assembly and inhibition of DNA strand transfer”. Nature. 464 (7286): 232—6. PMC 2837123 . PMID 20118915. doi:10.1038/nature08784.
Selwood T, Jaffe EK (2012). „Dynamic dissociating homo-oligomers and the control of protein function”. Arch. Biochem. Biophys. 519 (2): 131—43. PMC 3298769 . PMID 22182754. doi:10.1016/j.abb.2011.11.020.

Lodi PJ, Ernst JA, Kuszewski J, Hickman AB, Engelman A, Craigie R, Clore GM, Gronenborn AM (1995). „Solution structure of the DNA binding domain of HIV-1 integrase”. Biochemistry. 34 (31): 9826—33. PMID 7632683. doi:10.1021/bi00031a002.
Savarino A (2006). „A historical sketch of the discovery and development of HIV-1 integrase inhibitors”. Expert Opin Investig Drugs. 15 (12): 1507—22. PMID 17107277. doi:10.1517/13543784.15.12.1507.
Sax PE, DeJesus E, Mills A, Zolopa A, Cohen C, Wohl D, Gallant JE, Liu HC, Zhong L, Yale K, White K, Kearney BP, Szwarcberg J, Quirk E, Cheng AK (2012). „Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks”. Lancet. 379 (9835): 2439—48. PMID 22748591. doi:10.1016/S0140-6736(12)60917-9.
Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P (2010). „Retroviral intasome assembly and inhibition of DNA strand transfer”. Nature. 464 (7286): 232—6. PMC 2837123 . PMID 20118915. doi:10.1038/nature08784.
Selwood T, Jaffe EK (2012). „Dynamic dissociating homo-oligomers and the control of protein function”. Arch. Biochem. Biophys. 519 (2): 131—43. PMC 3298769 . PMID 22182754. doi:10.1016/j.abb.2011.11.020.

Morales-Ramirez JO, Teppler H, Kovacs C, et al. Antiretroviral effect of MK-0518, a novel HIV-1 integrase inhibitor, in ART-naïve HIV-1 infected patients. Program and abstracts of the 10th European AIDS Conference; November 17–20, 2005; Dublin, Ireland. Abstract LBPS1/6. Online summary: http://clinicaloptions.com/HIV/Conference%20Coverage/Dublin%202005/Capsules/LBPS1-6.aspx Архивирано на сајту Wayback Machine (29. октобар 2006)